A 76-year-old man with permanent non-valvular atrial fibrillation and hypertension presents for review. His CHA₂DS₂-VASc score is 3 (age, hypertension), HAS-BLED score 1, and he has normal renal function. He is currently taking aspirin 100 mg daily but no anticoagulant. According to Australian atrial fibrillation guidelines, what is the most appropriate change to his antithrombotic therapy?